Investment Summary |
|
|---|---|
| Date | 2018-07-01 |
| Target | Amryt Pharma |
| Sector | Life Science |
| Investor(s) | Athyrium Capital Management |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 4.6B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 33 of 50 |
| Sector: Life Science M&A | 16 of 24 |
| Type: Stake Purchase M&A Deals | 9 of 14 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2018 M&A | 5 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-23 |
Sound Physicians
Nashville, Tennessee, United States Sound Physicians is a physician-founded and led organization providing services across the acute episode of care - through emergency medicine, critical care, hospital medicine, transitional care and advisory services. Sound Physicians was founded in 2001 and is based in Nashville, Tennessee. |
Buy | $2.2B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-07-25 |
Agendia
Irvine, California, United States Agendia is a molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia was founded in 2003 and is based in Irvine, California. |
Buy | - |
